門冬氨酸鉀鎂注射液含有門冬氨酸鉀鹽、鎂鹽，為電解質(zhì)補充劑類藥物，臨床上主要用于低鉀血癥、低鉀及洋地黃中毒引起的心律失常、病毒性肝炎、肝硬化以及肝性腦病的治療。從門冬氨酸鉀鎂注射液的鑒別、含量測定、有關(guān)物質(zhì)、細(xì)菌內(nèi)毒素、無菌等方面分析總結(jié)了質(zhì)量研究現(xiàn)狀，系統(tǒng)歸納了該產(chǎn)品在心血管疾?。ㄐ穆墒С！⑿乃?、冠心病等）、肝臟疾?。ú《拘愿窝?、肝硬化等）的臨床應(yīng)用，為完善該制劑的質(zhì)量標(biāo)準(zhǔn)、提升質(zhì)量控制水平、臨床用藥安全提供參考。

Potassium Aspartate and Magnesium Aspartatse Injection is a compound preparation containing aspartate potassium salt,magnesium salt,and electrolyte supplements drugs.It is mainly used in the treatment of arrhythmia,viral hepatitis,cirrhosis and hepatic encephalopathy caused by hypokalemia,hypokalemia and digitalis poisoning.In this paper,the status of quality research was summarized from content determination,related substances,bacterial endotoxin,asepsis and so on,and systematically summarized the clinical application of this product in cardiovascular diseases (arrhythmia,heart failure,coronary heart disease,etc.),liver diseases (viral hepatitis,cirrhosis,etc.).It provided a reference for improving the quality standard,the level of quality control and clinical medication safety in Potassium Aspartate and Magnesium Aspartatse Injection.